IMMUNOHBs 180 IU/ml Injection

IMMUNOHBs 180 IU/ml Injection Uses, Dosage, Side Effects, Food Interaction and all others data.

Long-term hepatitis B immune globulin (HBIG) has been shown to reduce hepatitis B virus (HBV) reinfection in patients transplanted for hepatitis B. Infection with hepatitis B may lead to hepatocellular carcinoma, a type of liver cancer. Therefore, the hepatitis-B vaccines are cancer-preventing vaccines. According to the Centers for Disease Control and Prevention (CDC), the hepatitis B vaccine was the first anti-cancer vaccine.

HBIG is prepared from the plasma of donors who have high antibody levels of the hepatitis B surface antigen. It is extracted from the Cohn fraction II. During the process, viruses are deactivated, and in the final steps, solvents used in the preparation are removed. The preparation is tested for absence of HIV, HCV, herpes virus, and reovirus.

Table Of contents

• IMMUNOHBs 180 IU/ml Injection
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	IMMUNOHBs 180 IU/ml Injection
Generic	Hepatitis B immune globulin
Hepatitis B immune globulin Other Names	HBIG, Hepatitis B immune globulin, Hepatitis B immune globulin (human), Hepatitis B immune globulin human, Hepatitis B immunoglobulin (human), Human hepatitis B immunoglobulin, Human hepatitis B virus immune globulin, Human hepatitis-B immunoglobulin
Weight	180 IU/ml
Type	Injection
Groups	Approved, Investigational
Therapeutic Class
Manufacturer	ZAS Corporation
Available Country	Bangladesh
Last Updated:	September 24, 2024 at 5:38 am

Uses

IMMUNOHBs 180 IU/ml Injection is an injection of immunoglobulin G (IgG) antibodies to prevent the development of chronic Hepatitis B infection.

Investigated for use/treatment in hepatitis (viral, B), liver transplant surgery, and pediatric indications.

IMMUNOHBs 180 IU/ml Injection is also used to associated treatment for these conditions: Reactivation of hepatitis B virus infection, Post-exposure prophylaxis of hepatitis B

How IMMUNOHBs 180 IU/ml Injection works

In countries with high rates of hepatitis B infection, vaccination of newborns has not only reduced the risk of infection, but has also led to marked reduction in liver cancer.

Food Interaction

No interactions found.

Innovators Monograph

You find simplified version here IMMUNOHBs 180 IU/ml Injection